Janus kinase inhibitor tofacitinib is a potential therapeutic option for refractory eosinophilic fasciitis
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Clinical and experimental rheumatology - 38(2020), 3 vom: 20. Mai, Seite 567-568 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cao, Xiao-Yu [VerfasserIn] |
|---|
| Themen: |
87LA6FU830 |
|---|
| Anmerkungen: |
Date Completed 08.09.2020 Date Revised 08.09.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM304221716 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM304221716 | ||
| 003 | DE-627 | ||
| 005 | 20231225114526.0 | ||
| 007 | tu | ||
| 008 | 231225s2020 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1014.xml |
| 035 | |a (DE-627)NLM304221716 | ||
| 035 | |a (NLM)31820721 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cao, Xiao-Yu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Janus kinase inhibitor tofacitinib is a potential therapeutic option for refractory eosinophilic fasciitis |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 08.09.2020 | ||
| 500 | |a Date Revised 08.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Janus Kinase Inhibitors |2 NLM | |
| 650 | 7 | |a Piperidines |2 NLM | |
| 650 | 7 | |a Pyrimidines |2 NLM | |
| 650 | 7 | |a Pyrroles |2 NLM | |
| 650 | 7 | |a tofacitinib |2 NLM | |
| 650 | 7 | |a 87LA6FU830 |2 NLM | |
| 700 | 1 | |a Zhao, Jiu-Liang |e verfasserin |4 aut | |
| 700 | 1 | |a Hou, Yong |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Feng-Dan |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Zhao-Hui |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and experimental rheumatology |d 1989 |g 38(2020), 3 vom: 20. Mai, Seite 567-568 |w (DE-627)NLM012613010 |x 0392-856X |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2020 |g number:3 |g day:20 |g month:05 |g pages:567-568 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2020 |e 3 |b 20 |c 05 |h 567-568 | ||